FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HAYJOUR FAMILY LIMITED PARTNERSHIP

2. Date of Event Requiring Statement (MM/DD/YYYY)
8/26/2019 

3. Issuer Name and Ticker or Trading Symbol

Item 9 Labs Corp. [INLB]

(Last)        (First)        (Middle)

1709 EAST BETHANY HOME ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                          _____ 10% Owner
___X___ Officer (give title below)        _____ Other (specify below)
Executive Chairman /

(Street)

PHOENIX, AZ 85016      

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed(MM/DD/YYYY)

 

6. Individual or Joint/Group Filing(Check Applicable Line)

_X_ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common 1788903 D (1) 

Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Option 1/25/2013 1/25/2023 Common Stock 50000 $6.00 D  
Option 10/4/2013 10/4/2023 Common Stock 16667 $2.20 D  
Option 9/5/2014 9/5/2024 Common Stock 16667 $5.00 D  
Option 3/8/2016 3/8/2026 Common Stock 16667 $3.00 D  
Option 5/8/2019 5/8/2029 Common Stock 2500 $2.40 D  
Option 5/8/2020 5/8/2029 Common Stock 2500 $2.40 D  
Option 5/8/2021 5/8/2029 Common Stock 2500 $2.40 D  

Explanation of Responses:
(1) Hayjour Family Limited Partnership is controlled by Item 9 Labs Corp Executive Chairman, Jeffrey Rassas.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director10% OwnerOfficerOther
HAYJOUR FAMILY LIMITED PARTNERSHIP
1709 EAST BETHANY HOME ROAD
PHOENIX, AZ 85016


Executive Chairman

Signatures
Jeffrey Rassas8/28/2019
**Signature of Reporting PersonDate

Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Item 9 Labs (CE) Charts.
Item 9 Labs (CE) (USOTC:INLB)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Item 9 Labs (CE) Charts.